Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
24.9% overvalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
21
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
0.8% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
9
users have commented on this narrative
24
users have followed this narrative
10 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
5.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
45.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Modulight Oyj
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Laser Therapies Will Expand Precision Care For Aging Global Markets
Key Takeaways Expanded therapy indications, unique integration, and U.S. expansion could enable outsized market share capture and accelerate recurring revenue growth. Strategic partnerships and proprietary AI-driven devices position Modulight for premium pricing, income diversification, and sustained margin expansion.
View narrative
€2.20
FV
38.6% undervalued
intrinsic discount
41.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
BHIA
Grupo Casas Bahia
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Digitalization And Latin America Demand Will Drive Expansion
Key Takeaways Accelerated transformation, digitalization, and strategic financial backing position Grupo Casas Bahia for stronger margins, earnings growth, and superior operational efficiency over peers. Expanding omnichannel credit and consolidating specialty retail deepen market leadership, drive higher sales, and capitalize on rising middle-class consumption in Brazil.
View narrative
R$7.93
FV
64.2% undervalued
intrinsic discount
5.86%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
ANGLE
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Liquid Biopsy And Precision Medicine Will Reshape Cancer Care
Key Takeaways ANGLE's proprietary technology and expanding diagnostic menu position it as a foundational platform in oncology, enabling superior pricing and major industry adoption. Global expansion, recurring patient monitoring, and new data-driven partnerships are set to drive sustained, high-margin revenue growth well above current expectations.
View narrative
UK£0.37
FV
83.1% undervalued
intrinsic discount
220.69%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Lucid Diagnostics
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Aging Demographics And Medicare Coverage Will Spur Early Detection
Key Takeaways Accelerating insurance coverage, including Medicare and private payers, signals a tipping point for rapid test adoption and transformative revenue and margin growth. Scalable health system integration and operational infrastructure position Lucid to leverage rising demand for preventive diagnostics, supporting sustained, profitable expansion.
View narrative
US$7.39
FV
85.8% undervalued
intrinsic discount
115.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Tidewater Midstream and Infrastructure
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Rising Renewable Demand And Energy Transition Will Secure Market Position
Key Takeaways Tight renewable diesel supply, premium pricing, and regulatory credits position the company for accelerated margin and earnings growth beyond analyst expectations. Integration, cost synergies, and asset expansion underpin long-term cash flow stability, higher margins, and a defensible market niche amid global energy transition.
View narrative
CA$0.50
FV
57.0% undervalued
intrinsic discount
14.29%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Global Fashion Group
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Southeast Asia And Latin America Will Expand Digital Retail Markets
Key Takeaways Scaling AI and automation across regions could drive much greater margin expansion and profit growth than analysts currently anticipate. Expansion of private label and brand exclusives enhances margins and strengthens protection against competitive pressures, supporting resilient earnings and potential premiumization.
View narrative
€0.80
FV
55.0% undervalued
intrinsic discount
1.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Fortress Biotech
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Aging Population And Advancing Genomics Will Fuel Therapeutic Expansion
Key Takeaways Rapid Emrosi adoption and favorable cost structure could drive stronger-than-expected revenue and margin expansion. Platform strength and international deals support diversified, sustainable growth beyond existing product lifecycles.
View narrative
US$12.00
FV
81.3% undervalued
intrinsic discount
63.86%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
HBR Realty Empreendimentos Imobiliários
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
São Paulo Urbanization And Smart Technology Will Upgrade Mixed-Use Hubs
Key Takeaways Strong performance and expansion in premium São Paulo locations are driving higher-than-expected sales growth, margins, and asset value appreciation. Operational efficiencies, digital adoption, and a focus on mixed-use and hospitality assets support resilient, diversified income streams and industry-leading margin improvements.
View narrative
R$31.00
FV
88.1% undervalued
intrinsic discount
23.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Allbirds
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Upcoming Terralux And Aerie Launches Will Expand Global Footwear Markets
Key Takeaways Rapidly improving profitability, fueled by distributor strategy and strong demand for new products, is driving margins above expectations while supporting long-term growth. Sustainability leadership and omni-channel modernization boost brand equity, pricing power, and recurring revenue as eco-conscious consumers drive market shifts.
View narrative
US$14.00
FV
53.8% undervalued
intrinsic discount
4.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies